alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with scopolamine hydrobromide in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Layer, RT; Uretsky, NJ; Wallace, LJ | 1 |
Dikranian, K; Farber, NB; Heinkel, C; Jiang, XP; Kim, SH | 1 |
Alkalay, D; Brandeis, R; Cohen, G; Rabinovitz, I; Raveh, L; Sonego, H; Weissman, BA | 1 |
Carelli, V; Di Rienzo, B; Liberatore, F; Marra, R; Rispoli, V; Rotiroti, D; Scipione, L; Tortorella, S | 1 |
Del Arco, A; Mora, F; Segovia, G | 1 |
1 trial(s) available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and scopolamine hydrobromide
Article | Year |
---|---|
Caramiphen and scopolamine prevent soman-induced brain damage and cognitive dysfunction.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cognition Disorders; Cyclopentanes; Escape Reaction; Hypoxia, Brain; Male; Maze Learning; Prosencephalon; Rats; Rats, Sprague-Dawley; Reaction Time; Scopolamine; Soman; Swimming | 2002 |
4 other study(ies) available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and scopolamine hydrobromide
Article | Year |
---|---|
Effects of morphine in the nucleus accumbens on stimulant-induced locomotion.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amphetamine; Animals; Caffeine; Central Nervous System Stimulants; Dizocilpine Maleate; Dopamine Agents; Glutamine; Ibotenic Acid; Male; Morphine; Motor Activity; Neural Pathways; Nucleus Accumbens; Oligopeptides; Picrotoxin; Rats; Scopolamine; Synaptic Transmission | 1991 |
Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity.
Topics: Adrenergic alpha-Agonists; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Carbachol; Carbazoles; Cerebral Cortex; Clonidine; Dizocilpine Maleate; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Kainic Acid; Models, Neurological; Muscarinic Antagonists; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Phenazocine; Prosencephalon; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Receptors, Muscarinic; Receptors, N-Methyl-D-Aspartate; Receptors, sigma; Scopolamine | 2002 |
Electroencephalographic effects induced by choline pivaloyl esters in scopolamine-treated or nucleus basalis magnocellularis lesioned rats.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Basal Nucleus of Meynert; Choline; Choline O-Acetyltransferase; Dose-Response Relationship, Drug; Electroencephalography; Esters; Injections, Intraperitoneal; Male; Parasympathetic Nervous System; Parasympatholytics; Parietal Lobe; Rats; Rats, Wistar; Scopolamine | 2004 |
Blockade of NMDA receptors in the prefrontal cortex increases dopamine and acetylcholine release in the nucleus accumbens and motor activity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cholinergic Antagonists; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Flupenthixol; Glutamic Acid; Homovanillic Acid; Injections, Intraventricular; Male; Mecamylamine; Microinjections; Motor Activity; Muscarinic Antagonists; N-Methylaspartate; Nicotinic Antagonists; Nucleus Accumbens; Piperazines; Prefrontal Cortex; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Scopolamine | 2008 |